Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32735852)

  • 21. Impact of Pretreatment Combined (18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging on Radiation Therapy Treatment Decisions in Locally Advanced Breast Cancer.
    Ng SP; David S; Alamgeer M; Ganju V
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):111-7. PubMed ID: 26279029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of metabolic parameters in patients with synchronous colorectal cancer liver metastasis following curative-intent colorectal and hepatic surgery.
    Lee HS; Kim HO; Hong YS; Kim TW; Kim JC; Yu CS; Kim JS
    J Nucl Med; 2014 Apr; 55(4):582-9. PubMed ID: 24549284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer.
    Briggs RH; Chowdhury FU; Lodge JP; Scarsbrook AF
    Clin Radiol; 2011 Dec; 66(12):1167-74. PubMed ID: 21867996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
    Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
    Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The value of preoperative computed tomography combined with ultrasound in the investigation of small indeterminate liver lesions in patients with colorectal cancer.
    Abraham-Nordling M; Öistämö E; Josephson T; Hjern F; Blomqvist L
    Acta Radiol; 2017 Nov; 58(11):1288-1293. PubMed ID: 28286979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incremental value of liver MR imaging in patients with potentially curable colorectal hepatic metastasis detected at CT: a prospective comparison of diffusion-weighted imaging, gadoxetic acid-enhanced MR imaging, and a combination of both MR techniques.
    Kim HJ; Lee SS; Byun JH; Kim JC; Yu CS; Park SH; Kim AY; Ha HK
    Radiology; 2015 Mar; 274(3):712-22. PubMed ID: 25286324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of hepatic lymph node involvement by PET/CT in colorectal cancer patients with liver metastasis].
    Watanabe Y; Baba H; Hatano S; Matsuzawa T; Fukuchi M; Tsuji Y; Kumagai Y; Ishibashi K; Mochiki E; Ishida H
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1597-8. PubMed ID: 25731265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CT-Based Radiomics Analysis Before Thermal Ablation to Predict Local Tumor Progression for Colorectal Liver Metastases.
    Taghavi M; Staal F; Gomez Munoz F; Imani F; Meek DB; Simões R; Klompenhouwer LG; van der Heide UA; Beets-Tan RGH; Maas M
    Cardiovasc Intervent Radiol; 2021 Jun; 44(6):913-920. PubMed ID: 33506278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of routine clinical pretreatment 18F-FDG PET/CT in predicting outcome of colorectal liver metastasis.
    Tam HH; Cook GJ; Chau I; Drake B; Zerizer I; Du Y; Cunningham D; Koh DM; Chua SS
    Clin Nucl Med; 2015 May; 40(5):e259-64. PubMed ID: 25742225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
    Correa-Gallego C; Gavane S; Grewal R; Cercek A; Klimstra DS; Gewirtz AN; Kingham TP; Fong Y; DeMatteo RP; Allen PJ; Jarnagin WR; Kemeny N; D'Angelica MI
    HPB (Oxford); 2015 Jul; 17(7):644-50. PubMed ID: 26010778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST; Oyen WJ
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET/CT: will it change the way that we use CT in cancer imaging?
    Hicks RJ; Ware RE; Lau EW
    Cancer Imaging; 2006 Oct; 6(Spec No A):S52-62. PubMed ID: 17114079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative evaluation of colorectal liver metastases: comparison between gadoxetic acid-enhanced 3.0-T MRI and contrast-enhanced MDCT with histopathological correlation.
    Scharitzer M; Ba-Ssalamah A; Ringl H; Kölblinger C; Grünberger T; Weber M; Schima W
    Eur Radiol; 2013 Aug; 23(8):2187-96. PubMed ID: 23519439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.
    Brush J; Boyd K; Chappell F; Crawford F; Dozier M; Fenwick E; Glanville J; McIntosh H; Renehan A; Weller D; Dunlop M
    Health Technol Assess; 2011 Sep; 15(35):1-192, iii-iv. PubMed ID: 21958472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting liver metastases growth patterns: Current status and future possibilities.
    Oliveira RC; Alexandrino H; Cipriano MA; Alves FC; Tralhão JG
    Semin Cancer Biol; 2021 Jun; 71():42-51. PubMed ID: 32679190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
    Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
    Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer.
    Mhlanga JC; Evans AE; Doyle S; James JJ; Cornford EJ; Balls G; Chan SY; Ellis I
    Breast; 2011 Oct; 20(5):455-9. PubMed ID: 21596564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
    Cremolini C; Milione M; Marmorino F; Morano F; Zucchelli G; Mennitto A; Prisciandaro M; Lonardi S; Pellegrinelli A; Rossini D; Bergamo F; Aprile G; Urbani L; Morelli L; Schirripa M; Cardellino GG; Fassan M; Fontanini G; de Braud F; Mazzaferro V; Falcone A; Pietrantonio F
    Br J Cancer; 2018 Apr; 118(7):955-965. PubMed ID: 29531324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.